NICE Breast Cancer Referral Criteria Miss Up to 95% of Women Under 50

New research from the University of Cambridge and The Institute of Cancer Research reveals that NICE referral criteria used by GPs to identify women needing breast cancer risk assessment miss up to 95% of women under 50 who will develop the disease within 10 years. These findings highlight a critical gap in current screening protocols that may leave thousands of at-risk women without proper specialist evaluation. The study underscores the need for improved risk assessment strategies to better identify younger women at high risk of breast cancer. This discovery has significant implications for early detection and prevention efforts in primary care settings across healthcare systems.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: August 4, 2026 at 10:02 AM



